Roche Endorses ArQule’s Oncology Platform with US$276 M Alliance
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 47 (Table of Contents)
Published: 4 May-2004
DOI: 10.3833/pdr.v2004.i47.808 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Roche and ArQule entered into an agreement to develop anticancer therapeutics that exploit a new mechanistic approach to kill tumor cells selectively...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018